{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:46:52Z","timestamp":1793666812950,"version":"4.5.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDA12040215"],"award-info":[{"award-number":["XDA12040215"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.brainres.2018.11.034","type":"journal-article","created":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T18:09:23Z","timestamp":1543082963000},"page":"141-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["ScFv-conjugated superparamagnetic iron oxide nanoparticles for MRI-based diagnosis in transgenic mouse models of Parkinson\u2019s and Huntington\u2019s diseases"],"prefix":"10.1016","volume":"1707","author":[{"given":"Xiao-ge","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-qun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-lin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-tian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2018.11.034_b0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1748-0132(07)70084-1","article-title":"Magnetic nanoparticles for drug delivery","volume":"2","author":"Arruebo","year":"2007","journal-title":"Nano Today"},{"key":"10.1016\/j.brainres.2018.11.034_b0010","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/mds.26013","article-title":"Magnetic resonance imaging striatal volumes: a biomarker for clinical trials in Huntington's disease","volume":"29","author":"Aylward","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2018.11.034_b0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.brainres.2018.11.034_b0020","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.addr.2006.09.013","article-title":"Recent advances in iron oxide nanocrystal technology for medical imaging","volume":"58","author":"Corot","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.brainres.2018.11.034_b0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.gt.3302720","article-title":"Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery","volume":"13","author":"Dobson","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.brainres.2018.11.034_b0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4593","article-title":"Targeting protein aggregation for the treatment of degenerative diseases","volume":"14","author":"Eisele","year":"2015","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.brainres.2018.11.034_b0035","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bcp.2013.12.023","article-title":"Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins","volume":"88","author":"Guerrero-Munoz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2018.11.034_b0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2011.07.054","article-title":"Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease","volume":"310","author":"Ibarretxe-Bilbao","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2018.11.034_b0050","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(11)70152-1","article-title":"Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study","volume":"10","author":"Iranzo","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2018.11.034_b0055","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jalz.2015.05.002","article-title":"Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2","volume":"11","author":"Jack","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2018.11.034_b0060","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1021\/nl304287a","article-title":"Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery","volume":"13","author":"Jiang","year":"2013","journal-title":"Nano Lett."},{"key":"10.1016\/j.brainres.2018.11.034_b0065","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2018.11.034_b0070","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.brainres.2018.11.034_b0075","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0076-6879(06)13017-7","article-title":"Conformation-dependent anti-amyloid oligomer antibodies","volume":"413","author":"Kayed","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.brainres.2018.11.034_b0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-2-18","article-title":"Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers","volume":"2","author":"Kayed","year":"2007","journal-title":"Mol. Neurodegener."},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2018.11.034_b0085","first-page":"S67","article-title":"Molecular mechanisms of amyloid oligomers toxicity","volume":"33","author":"Kayed","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2018.11.034_b0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s13139-016-0435-8","article-title":"Current status and future direction of nanomedicine: focus on advanced biological and medical applications","volume":"51","author":"Kim","year":"2017","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.brainres.2018.11.034_b0095","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2018.11.034_b0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ana.22592","article-title":"Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease","volume":"71","author":"Kwon","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2018.11.034_b0105","doi-asserted-by":"crossref","DOI":"10.1007\/s12264-017-0174-6","article-title":"Can biomarkers help the early diagnosis of parkinson's disease?","author":"Le","year":"2017","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.brainres.2018.11.034_b0110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nm1467","article-title":"Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging","volume":"13","author":"Lee","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2018.11.034_b0115","first-page":"29","article-title":"Manganese-based layered double hydroxide nanoparticles as a T1 -MRI contrast agent with ultrasensitive ph response and high relaxivity","author":"Li","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.brainres.2018.11.034_b0120","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/mp900143a","article-title":"A novel type of dual-modality molecular probe for MR and nuclear imaging of tumor: preparation, characterization and in vivo application","volume":"6","author":"Liu","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.brainres.2018.11.034_b0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/jsre.2000.6030","article-title":"Clinical applications of magnetic drug targeting","volume":"95","author":"Lubbe","year":"2001","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.brainres.2018.11.034_b0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.brainres.2018.11.034_b0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.scr.2012.05.005","article-title":"Neuroprotective effects and magnetic resonance imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington's disease","volume":"9","author":"Moraes","year":"2012","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.brainres.2018.11.034_b0140","first-page":"14","article-title":"Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor-targeted cells and gliomas","volume":"Imaging","author":"Mu","year":"2015","journal-title":"Mol"},{"key":"10.1016\/j.brainres.2018.11.034_b0145","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1093\/brain\/awp209","article-title":"Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study","volume":"132","author":"Nandhagopal","year":"2009","journal-title":"Brain."},{"key":"10.1016\/j.brainres.2018.11.034_b0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4329\/wjr.v6.i6.301","article-title":"Neuroimaging in Huntington's disease","volume":"6","author":"Niccolini","year":"2014","journal-title":"World J Radiol."},{"key":"10.1016\/j.brainres.2018.11.034_b0155","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.progpolymsci.2010.08.005","article-title":"Iron oxide-based superparamagnetic polymeric nanomaterials: design, preparation, and biomedical application","volume":"36","author":"Oh","year":"2011","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.brainres.2018.11.034_b0160","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1039\/C6BM00504G","article-title":"High drug loading and pH-responsive targeted nanocarriers from alginate-modified SPIONs for anti-tumor chemotherapy","volume":"4","author":"Peng","year":"2016","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.brainres.2018.11.034_b0170","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1021\/nn300240p","article-title":"Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier","volume":"6","author":"Qiao","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.brainres.2018.11.034_b0175","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.nbd.2012.06.021","article-title":"Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study","volume":"48","author":"Ray","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2018.11.034_b0180","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1021\/cr300068p","article-title":"Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications","volume":"112","author":"Reddy","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.brainres.2018.11.034_b0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2018.11.034_b0190","first-page":"1013","article-title":"In vivo evaluation of Fe3O4 nanoparticles","volume":"55","author":"Roxana Cristina Popescy","year":"2014","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.brainres.2018.11.034_b0195","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","article-title":"Diagnosis and treatment of Parkinson disease: molecules to medicine","volume":"116","author":"Savitt","year":"2006","journal-title":"J Clin Invest."},{"key":"10.1016\/j.brainres.2018.11.034_b0200","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1073\/pnas.1117412109","article-title":"Molecular MRI enables early and sensitive detection of brain metastases","volume":"109","author":"Serres","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2018.11.034_b0205","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0140-6736(14)60041-6","article-title":"Imaging insights into basal ganglia function, Parkinson's disease, and dystonia","volume":"384","author":"Stoessl","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2018.11.034_b0210","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.addr.2008.03.018","article-title":"Magnetic nanoparticles in MR imaging and drug delivery","volume":"60","author":"Sun","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.brainres.2018.11.034_b0215","doi-asserted-by":"crossref","first-page":"375","DOI":"10.15403\/jgld.2014.1121.253.nan","article-title":"Magnetic nanoparticles for hepatocellular carcinoma diagnosis and therapy","volume":"25","author":"Ungureanu","year":"2016","journal-title":"J Gastrointestin Liver Dis."},{"key":"10.1016\/j.brainres.2018.11.034_b0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nnano.2014.254","article-title":"Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease","volume":"10","author":"Viola","year":"2015","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.brainres.2018.11.034_b0225","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.febslet.2008.12.064","article-title":"Conformation-dependent single-chain variable fragment antibodies specifically recognize beta-amyloid oligomers","volume":"583","author":"Wang","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.brainres.2018.11.034_b0230","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1073\/pnas.1620145114","article-title":"Exceedingly small iron oxide nanoparticles as positive MRI contrast agents","volume":"114","author":"Wei","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2018.11.034_b0235","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.mri.2007.04.016","article-title":"Detection of toxoplasmic lesions in mouse brain by USPIO-enhanced magnetic resonance imaging","volume":"25","author":"Wei","year":"2007","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.brainres.2018.11.034_b0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/jcbfm.2009.192","article-title":"Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review","volume":"30","author":"Weinstein","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainres.2018.11.034_b0245","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nature06917","article-title":"Imaging in the era of molecular oncology","volume":"452","author":"Weissleder","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2018.11.034_b0250","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.nano.2013.09.009","article-title":"In vivo MRI detection of carotid atherosclerotic lesions and kidney inflammation in ApoE-deficient mice by using LOX-1 targeted iron nanoparticles","volume":"10","author":"Wen","year":"2014","journal-title":"Nanomedicine."},{"key":"10.1016\/j.brainres.2018.11.034_b0255","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nn.3045","article-title":"Plasticity in gray and white: neuroimaging changes in brain structure during learning","volume":"15","author":"Zatorre","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2018.11.034_b0260","doi-asserted-by":"crossref","first-page":"36631","DOI":"10.1038\/srep36631","article-title":"A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses","volume":"6","author":"Zha","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2018.11.034_b0265","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1002\/adma.201600554","article-title":"Traceable nanoparticle delivery of small interfering rna and retinoic acid with temporally release ability to control neural stem cell differentiation for alzheimer's disease therapy","volume":"28","author":"Zhang","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.brainres.2018.11.034_b0270","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.bbapap.2011.09.005","article-title":"Conformation-dependent scFv antibodies specifically recognize the oligomers assembled from various amyloids and show colocalization of amyloid fibrils with oligomers in patients with amyloidoses","volume":"1814","author":"Zhang","year":"2011","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids"},{"key":"10.1016\/j.brainres.2018.11.034_b0275","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/15672050113106660176","article-title":"Pan-amyloid oligomer specific scFv antibody attenuates memory deficits and brain amyloid burden in mice with Alzheimer's disease","volume":"11","author":"Zhao","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.brainres.2018.11.034_b0285","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318306000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318306000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:44:24Z","timestamp":1775281464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899318306000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":54,"alternative-id":["S0006899318306000"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2018.11.034","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ScFv-conjugated superparamagnetic iron oxide nanoparticles for MRI-based diagnosis in transgenic mouse models of Parkinson\u2019s and Huntington\u2019s diseases","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2018.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}